Clinical Trial Update: New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for benign prostatic hyperplasia exploring new treatment strategies and an epigenetic biomarker; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms | Phase 2 | Status: RECRUITING